Bacillus Calmette-Guerin in the treatment of neoplastic disease.
D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D004195:Disease Models, Animal; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D001068:Feeding and Eating Disorders / Q000209:etiology; D005334:Fever / Q000209:etiology; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000009:adverse effects; D008107:Liver Diseases / Q000209:etiology; D051379:Mice; D008815:Mice, Inbred Strains; D009163:Mycobacterium bovis; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D012075:Remission, Spontaneous
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001500:BCG Vaccine